Learn more: To view or add a comment, sign in One of my biggest takeaways from the Novo Nordisk Africa Cardiometabolic Summit was this: Treating obesity isnt simply about losing weight
Severe Gastrointestinal Disorders and GLP-1 Safety Patients with a history of pancreatitis face increased risk on GLP-1 therapy
Even after retatrutide is approved, Mounjaro will still suit many people because it has a longer real-world safety record, a clearer cardiovascular profile, and produces clinically significant weight loss for most people who tolerate it
Beaupere C, Liboz A, Fve B, Blondeau B, Guillemain G
This heightened oxidative state can deplete glutathione stores, reducing its availability to combat oxidative damage
Weather changes, particularly cold and damp conditions, can also worsen symptoms